dbACP: A Comprehensive Database of Anti-Cancer Peptides

36 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp07889 H-58 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 0.62 ± 0.12 μM
dbacp07890 H-58 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 1.29 ± 0.08 μM
dbacp07891 H-58 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 2.13 ± 0.07 μM
dbacp07892 H-57 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 0.62 ± 0.12 μM
dbacp07893 H-57 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 1.29 ± 0.08 μM
dbacp07894 H-57 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 2.13 ± 0.07 μM
dbacp07895 H-18 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 0.89 ± 0.21 μM
dbacp07896 H-18 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 1.11 ± 0.21 μM
dbacp07897 H-18 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 1.61 ± 0.21 μM
dbacp07898 H-21 IKLSKS5TKKS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 3.26 ± 0.36 μM
dbacp07899 H-21 IKLSKS5TKKS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 3.05 ± 0.21 μM
dbacp07900 H-21 IKLSKS5TKKS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 1.50 ± 0.28 μM
dbacp07901 H-20 IKLSPS5TKKS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 2.10 ± 0.32 μM
dbacp07902 H-20 IKLSPS5TKKS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 2.63 ± 0.35 μM
dbacp07903 H-20 IKLSPS5TKKS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 4.93 ± 0.53 μM
dbacp07904 H-19 IKLSKETKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 1.00 ± 0.36 μM
dbacp07905 H-19 IKLSKETKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 1.78 ± 0.35 μM
dbacp07906 H-19 IKLSKETKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 1.64 ± 0.36 μM
dbacp07907 H-17 IKLSKS5TKKS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 0.96 ± 0.33 μM
dbacp07908 H-17 IKLSKS5TKKS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 1.49 ± 0.45 μM
dbacp07909 H-17 IKLSKS5TKKS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 1.64 ± 0.47 μM
dbacp07910 H-16 IKLSPS5TKKS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 1.85 ± 0.31 μM
dbacp07911 H-16 IKLSPS5TKKS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 2.65 ± 0.35 μM
dbacp07912 H-16 IKLSPS5TKKS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 3.14 ± 0.46 μM
dbacp07913 H-15 IKLSKS5TKDS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 2.26 ± 0.24 μM
dbacp07914 H-15 IKLSKS5TKDS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 2.95 ± 0.25 μM
dbacp07915 H-15 IKLSKS5TKDS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 2.20 ± 0.27 μM
dbacp07916 H-10 IKLSPS5TKDS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 3.59 ± 0.12 μM
dbacp07917 H-10 IKLSPS5TKDS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 3.51 ± 0.37 μM
dbacp07918 H-10 IKLSPS5TKDS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 1.50 ± 0.21 μM
dbacp07919 H-5 IKLSPETKDNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 7.35 ± 0.22 μM
dbacp07920 H-5 IKLSPETKDNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 4.16 ± 0.21 μM
dbacp07921 H-5 IKLSPETKDNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 2.82 ± 0.23 μM
dbacp07922 H-2 IKLSPS5TKDS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 4.26 ± 0.52 μM
dbacp07923 H-2 IKLSPS5TKDS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 3.54 ± 0.72 μM
dbacp07924 H-2 IKLSPS5TKDS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 1.60 ± 0.24 μM